Dupixent subcutaneous injection 200 mg syringe, manufactured by Sanofi, contains dupilumab (genetical recombination), a monoclonal antibody used to treat various inflammatory conditions. These include moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. It is supplied as 200mg 1.14mL 1 tube with YJ code 4490405G3027.
Dupixent subcutaneous injection 200 mg syringe
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).